Sung Ho Ryu Selected Research

human FPR2 protein

12/2008

Signal transduction of hyaluronic acid-peptide conjugate for formyl peptide receptor like 1 receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sung Ho Ryu Research Topics

Disease

28	Neoplasms (Cancer) 01/2022 - 10/2002
12	Insulin Resistance 02/2019 - 12/2011
9	Inflammation (Inflammations) 02/2016 - 06/2003
7	Obesity 01/2022 - 05/2009
7	Type 2 Diabetes Mellitus (MODY) 10/2020 - 12/2011
4	Breast Neoplasms (Breast Cancer) 01/2021 - 05/2013
4	Rheumatoid Arthritis 01/2019 - 08/2006
4	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 04/2007
4	Neoplasm Metastasis (Metastasis) 01/2016 - 10/2005
4	Hypoxia (Hypoxemia) 10/2015 - 05/2009
4	Pheochromocytoma 08/2006 - 03/2002
3	Carcinogenesis 11/2018 - 01/2008
3	Metabolic Diseases (Metabolic Disease) 09/2015 - 01/2009
3	Sepsis (Septicemia) 08/2015 - 12/2008
3	Infections 01/2014 - 10/2010
2	Body Weight (Weight, Body) 02/2019 - 12/2015
2	Arthritis (Polyarthritis) 01/2019 - 08/2006
2	Muscular Atrophy (Muscle Atrophy) 12/2017 - 04/2013
2	Colitis 01/2017 - 05/2015
2	Asthma (Bronchial Asthma) 02/2012 - 12/2008
2	Neuroblastoma 06/2011 - 01/2008
2	Starvation 10/2006 - 02/2002
2	Hypersensitivity (Allergy) 08/2006 - 12/2002
1	Lung Neoplasms (Lung Cancer) 02/2021
1	Chemical and Drug Induced Liver Injury 10/2019
1	Colorectal Neoplasms (Colorectal Cancer) 11/2018
1	Atherosclerosis 01/2018
1	Hyperinsulinism (Hyperinsulinemia) 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Disease Progression 01/2017
1	Proteinuria 01/2017
1	Hypertrophy 01/2017

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2008
9	Insulin (Novolin)FDA Link 01/2019 - 01/2009
7	Glucose (Dextrose)FDA LinkGeneric 02/2019 - 01/2014
6	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 04/2015 - 10/2003
6	Peptides (Polypeptides)IBA 11/2012 - 02/2002
5	Phospholipases (Phospholipase)IBA 01/2021 - 10/2002
5	Pharmaceutical PreparationsIBA 10/2020 - 12/2008
4	phospholipase D2IBA 08/2015 - 03/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2011 - 10/2005
3	1-dodecylpyridoxal (PLD)IBA 01/2022 - 03/2002
3	ErbB Receptors (EGF Receptor)IBA 02/2021 - 10/2005
3	LipidsIBA 01/2021 - 11/2012
3	EnzymesIBA 01/2021 - 06/2003
3	Protein Tyrosine PhosphatasesIBA 12/2017 - 04/2013
3	lysophosphatidic acidIBA 01/2017 - 06/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2014 - 10/2009
3	CytokinesIBA 07/2014 - 04/2010
3	Trp-Lys-Tyr-Met-Val-MetIBA 10/2010 - 02/2002
3	Epidermal Growth Factor (EGF)IBA 10/2008 - 01/2008
2	Phospholipase DIBA 01/2022 - 01/2017
2	Nucleotide AptamersIBA 02/2021 - 05/2013
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021 - 01/2010
2	Blood Glucose (Blood Sugar)IBA 10/2020 - 02/2019
2	Lipase (Acid Lipase)FDA Link 02/2019 - 01/2013
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 09/2015
2	AMP-Activated Protein KinasesIBA 12/2017 - 07/2011
2	Insulin Receptor Substrate ProteinsIBA 12/2017 - 04/2013
2	Dextrans (Dextran)FDA Link 01/2017 - 05/2015
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2017 - 01/2017
2	Hormones (Hormone)IBA 01/2016 - 11/2014
2	GlucocorticoidsIBA 01/2016 - 04/2013
2	Oxygen (Dioxygen)IBA 10/2015 - 08/2014
2	Nonesterified Fatty Acids (NEFA)IBA 09/2015 - 04/2015
2	Chemotactic FactorsIBA 07/2014 - 02/2012
2	Conditioned Culture MediaIBA 09/2012 - 04/2010
2	Small Interfering RNA (siRNA)IBA 04/2012 - 06/2011
2	BradykininIBA 06/2011 - 03/2002
2	AGRO 100IBA 01/2010 - 01/2010
2	NucleolinIBA 01/2010 - 01/2010
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 10/2009 - 04/2007
2	Indicators and Reagents (Reagents)IBA 05/2009 - 10/2006
2	CalciumIBA 10/2006 - 08/2006
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 08/2006 - 10/2002
1	Uncoupling Protein 1IBA 01/2022
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2021
1	Nucleic AcidsIBA 02/2021
1	Tyrosine Kinase InhibitorsIBA 02/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 10/2020
1	5-imidazolepropionic acidIBA 10/2020
1	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 02/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Oleic Acid (Oleate)IBA 01/2018
1	dihydrotanshinone IIBA 12/2017
1	Cetuximab (Erbitux)FDA Link 07/2017
1	SodiumIBA 01/2017
1	Tight Junction ProteinsIBA 01/2017
1	OccludinIBA 01/2017
1	nephrinIBA 01/2017
1	GTP Phosphohydrolases (GTPases)IBA 01/2017
1	TOR Serine-Threonine KinasesIBA 01/2017
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 10/2016
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 10/2016
1	ResveratrolIBA 02/2016
1	PolyphenolsIBA 02/2016

Therapy/Procedure

3	Therapeutics 10/2020 - 01/2016